Logo image of ALBI.PA

GASCOGNE (ALBI.PA) Stock Fundamental Analysis

EPA:ALBI - FR0000124414 - Common Stock

2.34 EUR
0 (0%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

2

ALBI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 14 industry peers in the Containers & Packaging industry. Both the profitability and financial health of ALBI have multiple concerns. ALBI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ALBI has reported negative net income.
In the past year ALBI had a positive cash flow from operations.
ALBI had positive earnings in 4 of the past 5 years.
ALBI had a positive operating cash flow in each of the past 5 years.
ALBI.PA Yearly Net Income VS EBIT VS OCF VS FCFALBI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

1.2 Ratios

ALBI has a worse Return On Assets (-0.10%) than 76.92% of its industry peers.
The Return On Equity of ALBI (-0.29%) is worse than 76.92% of its industry peers.
With a Return On Invested Capital value of 0.88%, ALBI is not doing good in the industry: 69.23% of the companies in the same industry are doing better.
Measured over the past 3 years, the Average Return On Invested Capital for ALBI is below the industry average of 6.41%.
Industry RankSector Rank
ROA -0.1%
ROE -0.29%
ROIC 0.88%
ROA(3y)2.18%
ROA(5y)2.37%
ROE(3y)5.63%
ROE(5y)6.16%
ROIC(3y)4.1%
ROIC(5y)4.24%
ALBI.PA Yearly ROA, ROE, ROICALBI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

1.3 Margins

With a Operating Margin value of 1.55%, ALBI is not doing good in the industry: 69.23% of the companies in the same industry are doing better.
ALBI's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 25.55%, ALBI is doing worse than 76.92% of the companies in the same industry.
ALBI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.55%
PM (TTM) N/A
GM 25.55%
OM growth 3Y-27.15%
OM growth 5Y-15.85%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.32%
GM growth 5Y-1.26%
ALBI.PA Yearly Profit, Operating, Gross MarginsALBI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

2

2. Health

2.1 Basic Checks

ALBI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for ALBI has been increased compared to 1 year ago.
ALBI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ALBI is higher compared to a year ago.
ALBI.PA Yearly Shares OutstandingALBI.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ALBI.PA Yearly Total Debt VS Total AssetsALBI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

ALBI has an Altman-Z score of 1.29. This is a bad value and indicates that ALBI is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.29, ALBI is doing worse than 76.92% of the companies in the same industry.
ALBI has a Debt/Equity ratio of 1.19. This is a high value indicating a heavy dependency on external financing.
ALBI's Debt to Equity ratio of 1.19 is on the low side compared to the rest of the industry. ALBI is outperformed by 76.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.19
Debt/FCF N/A
Altman-Z 1.29
ROIC/WACC0.26
WACC3.43%
ALBI.PA Yearly LT Debt VS Equity VS FCFALBI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 1.79 indicates that ALBI should not have too much problems paying its short term obligations.
ALBI has a better Current ratio (1.79) than 76.92% of its industry peers.
ALBI has a Quick Ratio of 1.07. This is a normal value and indicates that ALBI is financially healthy and should not expect problems in meeting its short term obligations.
ALBI's Quick ratio of 1.07 is amongst the best of the industry. ALBI outperforms 84.62% of its industry peers.
Industry RankSector Rank
Current Ratio 1.79
Quick Ratio 1.07
ALBI.PA Yearly Current Assets VS Current LiabilitesALBI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

1

3. Growth

3.1 Past

ALBI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -122.74%.
The Revenue has decreased by -4.87% in the past year.
ALBI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.07% yearly.
EPS 1Y (TTM)-122.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%178.98%
Revenue 1Y (TTM)-4.87%
Revenue growth 3Y-0.64%
Revenue growth 5Y0.07%
Sales Q2Q%7.54%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALBI.PA Yearly Revenue VS EstimatesALBI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALBI. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALBI.PA Price Earnings VS Forward Price EarningsALBI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALBI indicates a somewhat cheap valuation: ALBI is cheaper than 61.54% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.16
ALBI.PA Per share dataALBI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALBI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GASCOGNE

EPA:ALBI (9/5/2025, 7:00:00 PM)

2.34

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners1.62%
Ins Owner ChangeN/A
Market Cap88.17M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.23
P/FCF N/A
P/OCF 4.03
P/B 0.41
P/tB 0.44
EV/EBITDA 7.16
EPS(TTM)-0.07
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.13
FCFYN/A
OCF(TTM)0.58
OCFY24.81%
SpS10.38
BVpS5.69
TBVpS5.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.1%
ROE -0.29%
ROCE 1.29%
ROIC 0.88%
ROICexc 1.11%
ROICexgc 1.15%
OM 1.55%
PM (TTM) N/A
GM 25.55%
FCFM N/A
ROA(3y)2.18%
ROA(5y)2.37%
ROE(3y)5.63%
ROE(5y)6.16%
ROIC(3y)4.1%
ROIC(5y)4.24%
ROICexc(3y)4.63%
ROICexc(5y)4.82%
ROICexgc(3y)4.81%
ROICexgc(5y)5.01%
ROCE(3y)6.32%
ROCE(5y)6.56%
ROICexcg growth 3Y-40.81%
ROICexcg growth 5Y-24.33%
ROICexc growth 3Y-40.44%
ROICexc growth 5Y-24.35%
OM growth 3Y-27.15%
OM growth 5Y-15.85%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.32%
GM growth 5Y-1.26%
F-Score3
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 1.19
Debt/FCF N/A
Debt/EBITDA 8.29
Cap/Depr 260.52%
Cap/Sales 16.52%
Interest Coverage 1.29
Cash Conversion 70.88%
Profit Quality N/A
Current Ratio 1.79
Quick Ratio 1.07
Altman-Z 1.29
F-Score3
WACC3.43%
ROIC/WACC0.26
Cap/Depr(3y)285.57%
Cap/Depr(5y)222.94%
Cap/Sales(3y)15.49%
Cap/Sales(5y)11.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-122.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%178.98%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.87%
Revenue growth 3Y-0.64%
Revenue growth 5Y0.07%
Sales Q2Q%7.54%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-66.43%
EBIT growth 3Y-27.62%
EBIT growth 5Y-15.79%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y10.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-35.07%
OCF growth 3Y-14.16%
OCF growth 5Y0.18%